-+ 0.00%
-+ 0.00%
-+ 0.00%

DYNE THERAPEUTICS RECEIVES EUROPEAN MEDICINES AGENCY (EMA) ORPHAN DRUG DESIGNATION FOR DYNE-251 IN DUCHENNE MUSCULAR DYSTROPHY

Reuters·04/24/2025 11:30:00

Please log in to view news